Cargando…
Fluid and Biopsy Based Biomarkers in Parkinson’s Disease
Several advances in fluid and tissue-based biomarkers for use in Parkinson’s disease (PD) and other synucleinopathies have been made in the last several years. While work continues on species of alpha-synuclein (aSyn) and other proteins which can be measured from spinal fluid and plasma samples, imm...
Autores principales: | Coughlin, David G., Irwin, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10457253/ https://www.ncbi.nlm.nih.gov/pubmed/37138160 http://dx.doi.org/10.1007/s13311-023-01379-z |
Ejemplares similares
-
Diagnostic cerebrospinal fluid biomarkers for Parkinson's disease: A pathogenetically based approach
por: van Dijk, Karin D., et al.
Publicado: (2010) -
Blood and Cerebrospinal Fluid Biomarkers of Inflammation in Parkinson’s Disease
por: Zimmermann, Milan, et al.
Publicado: (2022) -
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
por: Irwin, David J., et al.
Publicado: (2020) -
Brain-Biomarker Changes in Body Fluids of Patients with Parkinson’s Disease
por: Cocco, Cristina, et al.
Publicado: (2023) -
Circular RNAs in body fluids as cancer biomarkers: the new frontier of liquid biopsies
por: Wang, Sumeng, et al.
Publicado: (2021)